Ani Pharmaceuticals Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 3.73, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Ani Pharmaceuticals Inc in Sep 30 2026 quarter, has decreased to 98 days, compared to 99 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 458 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1748 to 3075.

What is Receivable Turnover Ratio?
What is Ani Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ANIP Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	20.52 %	21.63 %	15.93 %	26.77 %	28.65 %
Y / Y Revenue Change	27.64 %	25.87 %	20.46 %	29.64 %	53.58 %
Receivable Turnover Ratio (TTM)	3.73	3.68	3.64	3.61	3.59
ANIP's Total Ranking	# 3075	# 1748	# 2697	# 707	#
Accounts Receivable average collection period days	98	99	100	101	102
Seq. Receivable Change	10.92 %	7.45 %	-9.13 %	11.27 %	11.95 %
Seq. Revenue Change	9.3 %	12.04 %	-3.88 %	8.45 %	7.78 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 142
Healthcare Sector	# 459
Overall Market	# 3075

Receivable Turnover Ratio Statistics
High	Average	Low
8.58	3.25	1.94
(Jun 30 2013)		(Jun 30 2022)

ANIP Company Profile • Back to ANIP Efficiency Comparisons • Compare ANIP Receivables Turnover Ratio to its Competitors

Financial Statements
Ani Pharmaceuticals Inc's Accounts Receivable	$ 304 Millions	Visit ANIP's Balance sheet
Ani Pharmaceuticals Inc's Sales TTM	$ 1,041 Millions	Visit ANIP's Income Statement
Sources of ANIP's Revenues		Visit ANIP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ANIP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ANIP's Growth Rates	ANIP's Roa	ANIP's Inventory Turnover Ratio	ANIP's Dividend Comparisons
ANIP's Profitability Ratios	ANIP's Roi	ANIP's Asset Turnover Ratio	ANIP's Dividend Growth
ANIP's Valuation Ratios	ANIP's Roe	ANIP's Financial Strength Ratios	ANIP's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Co diagnostics Inc	9.12	$ 0.859 Millions	$ 0.094 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Acadia Pharmaceuticals Inc	8.46	$ 1,202.301 Millions	$ 142.117 Millions
Novavax inc	8.33	$ 411.649 Millions	$ 49.414 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Tela Bio Inc	8.16	$ 79.525 Millions	$ 9.743 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Sonoma Pharmaceuticals Inc	8.05	$ 23.490 Millions	$ 2.918 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Protalix Biotherapeutics inc	8.03	$ 84.693 Millions	$ 10.549 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Koru Medical Systems Inc	7.84	$ 46.272 Millions	$ 5.901 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Trisalus Life Sciences Inc	7.78	$ 47.397 Millions	$ 6.090 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Anteris Technologies Global Corp	7.73	$ 2.332 Millions	$ 0.302 Millions
Madrigal Pharmaceuticals Inc	7.70	$ 1,427.940 Millions	$ 185.380 Millions
Lemaitre Vascular Inc	7.66	$ 269.938 Millions	$ 35.235 Millions

Date modified: 2026-11-09T06:44:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.